The CEVA group is a dedicated department within IQVIA that specializes in the compilation and management of study committees. CEVA endpoint adjudication pillar supports committees that need to review additional data related to a specific event, timepoint, lab result etc. that needs to be gathered from sites or external vendors and this group primarily supports endpoint adjudication committees.
This case study outlines how: The IQVIA CEVA team delivered a unique blend of innovation, technical expertise, and adaptive strategies to overcome tight timelines and meet client targets for their COVID-19 therapeutic trial.
Related solutions
Harness the power of global human expertise combined with automation, artificial intelligence (AI) and machine learning (ML) to design, build and execute end-to-end safety solutions.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
